A new, high-throughput high- Performance liquid chromatographic/mass spectrometric assay for therapeutic level monitoring of digoxin in human plasma

Journal of AOAC International

Volumn 92, Issue 5, 2009, Pages 1390-1395

  Vlase, Laurian ^a   Popa, Daniela Saveta ^a   Muntean, Dana ^a   Mihu, Dan ^a   Leucuta, Sorin ^a  

^a IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

LEVEL MEASUREMENT; PLASMA (HUMAN); SODIUM COMPOUNDS;

BIOEQUIVALENCE STUDY; CHROMATOGRAPHIC SYSTEMS; HIGH-THROUGHPUT METHOD; HUMAN PLASMA SAMPLES; ISOCRATIC CONDITIONS; PERCHLORIC ACIDS; SELECTED ION MONITORING; THERAPEUTIC LEVELS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

EID: 70449394261     PISSN: 10603271     EISSN: None     Source Type: Journal    
DOI: 10.1093/jaoac/92.5.1390     Document Type: Article

References (20)

1. Anderson, P., Knoben, J., & Troutman, W. (Eds) (2002) Handbook of Clinical Drug Data, 10th Ed., McGraw-Hill, New York, NY, pp 300-302
2. Newman, R. A., Yang, P., Pawlus, A. D., & Block, K. I. (2008) Mol. Interv. 8, 36-49
3. Smalley, J., Marino, A. M., Xin, B., Olah, T., & Balimane, P. V. (2007) J. Chromatogr. B 854, 260-267
4. Yao, M., Zhang, H., Chong, S., Zhu, M., & Morrison, R. A. (2003) J. Pharm. Biomed. Anal. 32, 1189-1197
5. Higashi, Y., Ikeda, Y., Yamamoto, R., Yamashiro, M., & Fujii, Y. (2005) Life Sci. 77, 1055-1167
6. Erol, K., Kilic, F. S., Batu, O. S., & Yildirim, E. (2001) Chronobiol. Int. 18, 841-849
7. Borges, N. C., Guermani, A., Mazucheli, J. A., Mendes, G. D., & Moreno, R. A. (2007) Int. J. Clin. Pharmacol. Ther. 45, 366-372
8. Schultz, R. A., Kellerman, T. S., & Van Den Berg, H. (2005) OnderstepoortJ. Vet. Res. 72, 189-201
9. Tracqui, A., Kintz, P., Ludes, B., & Mangin, P. (1997) J. Chromatogr. B 692, 101-109
10. Tzou, M. C., & Sams, R. A. (1995) J. Pharm. Biomed. Anal. 13, 1531-1540
11. Graefe, K. A., Tang, Z., & Karnes H. T. (2000) J. Chromatogr. B 745, 305-314
12. Oosterkamp, A. J., Irth, H., Beth, M., Unger, K. K., Tjaden, U. R., & van de Greef, J. (1994) J. Chromatogr. B 653, 55-61
13. Kirby, B. J., Kalhorn, T., Hebert, M., Easterling, T., & Unadkat, J. D. (2008) Biomed. Chromatogr. 22, 712-718
14. Mitamura, K., Horikawa, A., Yamane, Y., Ikeda, Y., Fujii, Y., & Shimada, K. (2007) Biol. Pharm. Bull. 30, 1653-1656
15. Hashimoto, Y., Shibakawa, K., Nakade, S., & Miyata, Y. (2008) J. Chromatogr. B 869, 126-132
16. Kaiser, P., Akerboom, T., Wood, W. G., & Reinauer, H. (2006) Clin. Lab. 52, 37-42
17. Kaiser, P., Kramer, U., Meissner, D., Kress, M., Wood, W. G., & Reinauer, H. (2003) Clin. Lab. 49, 329-343
18. Frommherz, L., Köhler, H., Brinkmann, B., Lehr, M., & Beike, J. (2008) Int. J. Legal Med. 122, 109-114
19. Guidance for Industry, Bioanalytical Method Validation (2001) U. S. Department of Health and Human Services, U. S. Food and Drug Administration, Fed. Regist. 66, 4-15
20. Guidance on the Investigation of Bioavailability and Bioequivalence (2001) The European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products, Canary Wharf, London, UK